Literature DB >> 10626834

Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.

K W Kim1, J H Jhoo, K U Lee, D Y Lee, J H Lee, J Y Youn, B J Lee, S H Han, J I Woo.   

Abstract

We analyzed the aplolipoprotein E (APOE) genotypes of 110 probable AD patients and 226 cognitively normal controls in Koreans. The APOE epsilon4 allele was more prevalent in both early- and late-onset AD patients (P < 0.01) than in controls. The odds for the APOE epsilon4-heterozygous subjects were 2.7 (95% CI = 1.6-4.5), and those for the APOE epsilon4-homozygous subjects were 17.4 (95% CI = 2.0-147.3). But the odds were not uniform across age groups, and were higher in women than in men. Although the APOE epsilon2 allele frequency did not differ by diagnosis, the patients carrying an APOE epsilon2 allele showed delayed age-at-onset (P = 0.02). In conclusion, the APOE e4 allele increased the risk for AD in dose-dependent manner, and the APOE epsilon4-conferred AD risk was age- and sex-dependent in Koreans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10626834     DOI: 10.1016/s0304-3940(99)00867-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  14 in total

Review 1.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

2.  High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population.

Authors:  Afef Achouri Rassas; Hela Mrabet Khiari; Sondes Hadj Fredj; Safa Sahnoun; Hend Batti; Nouria Oudiaa Zakraoui; Aroua Cherif; Nadia Anane; Nadia Ben Ali; Taieb Messaoud; Amel Mrabet
Journal:  Neurol Sci       Date:  2011-06-28       Impact factor: 3.307

3.  APOE, MTHFR, LDLR and ACE polymorphisms among Angami and Lotha Naga populations of Nagaland, India.

Authors:  Benrithung Murry; Neikethono Vakha; Nongthombam Achoubi; M P Sachdeva; K N Saraswathy
Journal:  J Community Health       Date:  2011-12

4.  Late onset Alzheimer's disease and apolipoprotein association in the Irish population: relative risk and attributable fraction.

Authors:  Z Hawi; K Sheehan; A Lynch; I Evans; N Lowe; B Lawlor; M Gill
Journal:  Ir J Med Sci       Date:  2003 Apr-Jun       Impact factor: 1.568

Review 5.  Exercise, APOE genotype, and the evolution of the human lifespan.

Authors:  David A Raichlen; Gene E Alexander
Journal:  Trends Neurosci       Date:  2014-03-30       Impact factor: 13.837

Review 6.  Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies.

Authors:  Irene López González; Paula Garcia-Esparcia; Franc Llorens; Isidre Ferrer
Journal:  Int J Mol Sci       Date:  2016-02-04       Impact factor: 5.923

7.  Apolipoprotein ε7 allele in memory complaints: insights through protein structure prediction.

Authors:  Young Chul Youn; Yong Kwan Lim; Su-Hyun Han; Vo Van Giau; Mi-Kyung Lee; Kwang-Yeol Park; SangYun Kim; Eva Bagyinszky; Seong Soo A An; Hye Ryoun Kim
Journal:  Clin Interv Aging       Date:  2017-07-11       Impact factor: 4.458

8.  The Effect of Choline Acetyltransferase Genotype on Donepezil Treatment Response in Patients with Alzheimer's Disease.

Authors:  Kang Uk Lee; Jung Hie Lee; Dong Young Lee; Jong Chul Youn; Jeong Lan Kim; Seok Woo Moon; Bong-Jo Kim; Seung-Ho Ryu; Moon Doo Kim; Chang-Uk Lee; Nam-Jin Lee; Sung Man Chang; Young Hoon Kim; Do Hoon Kim; Hae-Kook Lee; Jong Inn Woo; Ki Woong Kim; Jin Hyeong Jhoo
Journal:  Clin Psychopharmacol Neurosci       Date:  2015-08-31       Impact factor: 2.582

9.  The nitric oxide synthase 3 G894T polymorphism associated with Alzheimer's disease risk: a meta-analysis.

Authors:  Shengyuan Liu; Fangfang Zeng; Changyi Wang; Zhongwei Chen; Bin Zhao; Keshen Li
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

Review 10.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.